Expert shares advice and tools for Houston companies returning to their office space

Guest column

More and more Houston companies are having employees return to the office, but business leaders should take advantage of new tools and best practices. Getty Images

As states begin to relax their stay-at-home orders and communities plan for the reopening of local economies, many may be returning to work and engaging in more regular social activity. While the return to some semblance of normalcy may come as a relief, questions about one's own health or the health of family members may remain.

Upon returning to work, people should continue to be smart and cautious while interacting with others. Following CDC guidelines and maintaining social distancing, practicing good hand hygiene and frequently sanitizing common areas or high-contact items, including doorknobs, hand railings and communal phones and printers, can be good preventive measures to help mitigate COVID-19 health risks.

Business associations, health systems, and governments are crafting guidelines to help mitigate risks associated with reopening communities, but additional resources may be available to help individuals navigate their own physical and mental health during this transition period.

Many may continue to have questions related to potential COVID-19 symptoms. To help, UnitedHealthcare provides an online COVID-19 symptom self-checker to help people gauge their symptoms and consider what may be the next steps for care. The symptom self-checker is at no additional cost for people to access, and users of the self-checker tool will be asked to answer a series of questions to generate feedback on care options to consider, which then assigns assessment levels ranging from self-isolation to emergency care, depending on the severity and urgency of the symptoms recorded. A testing site locator feature provides updated information on nearby COVID-19 testing sites if recommended by a physician.

Some people may still need to see a doctor but may worry about the potential risk of exposure (or the risk of exposing others) with in-person visits to a physician's office or urgent care center. As an alternative starting point for care, some people may continue to consider telehealth, which enables people to connect 24/7 with a health care provider via a smart phone, tablet or desktop computer. Telehealth may be especially helpful as an initial option for medical advice related to COVID-19, and to help evaluate other possible health issues, such as allergies, pink eye or the flu.

Employers also have a tool available for their employees. ProtectWell, a new smartphone app just launched by Microsoft and UnitedHealth Group, screens employees for COVID-19. Employees found to be at-risk for COVID-19 are directed to get a test and the app notifies employers of the results. The ProtectWell app is offered to all employers in the United States at no charge.

Access to mental health resources may also continue to be an important tool for people to have as they head back to work. Being at home and perhaps feeling isolated over the last few months may have had an impact on one's mental health, and the loneliness people may be experiencing, as well as possible stress or anxiety brought on by the pandemic, should be considered alongside physical health.

Virtual mental health resources are available for those experiencing increased stress and anxiety. A free emotional support line (866-342-6892) is available 24/7 to the public courtesy of Optum, which is part of UnitedHealth Group. Staffed by mental health professionals, individuals may receive help without taking any unnecessary trips.

Available at no additional cost, mental health and wellness apps, like Sanvello, may also be great resources for coping with the ongoing stress and anxiety. Equipped with self-care tools, peer support groups, coaching and therapy, Sanvello offers a number of avenues to receive the help and support one may need as they return to work.

For people who used mental health services before COVID-19, some care providers offer long-distance counseling and other resources, enabling for continued care from the comfort of home. Check with your providers regarding options on what may work best for you.

Taking care of physical and mental health needs may be imperative in the coming weeks and months as communities strive to reopen and individuals resume more familiar living routines. Using online and telehealth services may play a role in facilitating a smoother and healthier transition.

------

Dr. Sarah-Anne Schumann is the chief medical officer for UnitedHealthcare of Oklahoma and North Texas.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

New UH survey reveals concerns over AI data center growth in Houston

data findings

A new report out of the University of Houston shows that area residents remain wary of the long-term effects of operating data centers.

The recent survey from the University of Houston’s latest SPACE City Panel, conducted by the Center for Public Policy at the Hobby School of Public Affairs, shows that while 85 percent of Houston-area residents use AI, nearly 63 percent oppose the construction of AI data centers within 1 mile of their homes.

Respondents’ concerns centered around data centers’ high energy demand and the area’s power grid reliability. According to the survey, 32 percent of residents who oppose local data center projects would be more likely to support the centers if they relied on renewable energy over fossil fuels.

“Respondents understand that AI can bring economic and educational benefits, but they are also concerned about the physical infrastructure needed to fuel AI, especially data centers,” Soran Mohtadi, post-doctoral fellow at the Hobby School and a researcher on the report, said in a news release. “This physical infrastructure demands more electricity and water, leading to environmental impacts.”

Experts estimate that 6.5 gigawatts of data center capacity will be added to the Texas grid by 2030. And Houston’s data center capacity is predicted to more than double by 2028.

The Electric Reliability Council of Texas also projects electricity demand could reach 218 gigawatts by 2031, which would be more than double the record peak set in August 2023. Data centers are expected to account for 86 gigawatts of that new demand.

Survey respondents also said they are concerned about the state's future water supply, given the large amounts of water that data centers need to stay cool.

In terms of who’s responsible for that issue, 57.6 percent of respondents said they put the onus on Texas lawmakers, while 31.5 percent say tech companies should be responsible.

Additionally, more than 75 percent of respondents believed that data center developers and technology companies—not residents—should bear the cost of infrastructure upgrades to support data centers.

“Every decision legislators make has implications on residents’ everyday lives and local infrastructure now and in the future,” Maria P. Perez Arguelles, lead researcher on the report and research assistant professor at the Hobby School, added in the news release. “This issue is going to become more important in years to come, so this is just the beginning.”

Read the full report here.

Houston-born Cemvita makes breakthrough in sustainable fuel production

clean fuels

Houston-based biotech company Cemvita announced that it recently reached a critical milestone in the development of its FermOil product, which can be used to create Sustainable Aviation Fuel (SAF) and other renewable fuels at industrial scale.

The company shared in a news release that it completed a 75,000-liter industrial fermentation run at Belgium's Bio Base Europe Pilot Plant.

The campaign achieved target technical metrics for the production of FermOil, Cemvita’s renewable natural oil (RNO). FermOil is produced from industrial crude glycerin, an industrial byproduct, as opposed to traditional sugar-based feedstocks used in many bio-oil fermentation processes. It's designed to be a drop-in feedstock for creating SAFs.

Cemvita had previously advanced its FermOil production process through multiple scale-up stages before successfully reaching the 75,000-liter demonstration campaign, according to the company.

“This is not just a fermentation milestone,” Moji Karimi, CEO at Cemvita, said in the release. “It is a blueprint for how existing industrial infrastructure can evolve into circular bioeconomy infrastructure. Every biodiesel plant generating crude glycerin is a potential platform for renewable natural oil production.”

The milestone also supports the deployment of Cemvita’s industrial biomanufacturing platform, FermWorks, which integrates with existing energy and industrial infrastructure to turn waste carbon streams into SAFs and other materials. According to the release, Cemvita plans to move forward with commercial deployment discussions with partners in Brazil, Europe and in the UK. Cemvita already has a partnership with the Brazilian sustainable research institution REMA.

“We are proud to support innovative companies like Cemvita in scaling breakthrough industrial biotechnology solutions,” Hendrik Waegeman, head of business operations at Bio Base Europe Pilot Plant, added in the release. “Successfully operating at the 75,000-liter scale using a feedstock such as crude glycerin highlights both the maturity of the technology and the quality of the scale-up execution achieved by the Cemvita team.”

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Eli Lilly scoops up Houston biotech startup in $300 million deal

big pharma deal

Pharmaceutical giant Eli Lilly has acquired Houston biotech startup CrossBridge Bio, which develops antibody-drug conjugates for cancer, in a deal worth up to $300 million. The deal was celebrated by TMC Venture Fund and the University of Texas Health Science Center at Houston last week.

CrossBridge, founded in 2023, is developing ADCs based on research by Kyoji Tsuchikama and Zhiqiang An, both of UT Health Houston. Tsuchikama is an associate professor of medicinal chemistry and a globally recognized ADC pioneer, and An is a professor of molecular science and vice president of drug discovery.

Antibody-drug conjugates (ADCs) are a potent combination of targeted therapy and chemotherapy that kills cancer cells while saving healthy tissue.

Clinical trials for CrossBridge’s primary ADC candidate, CBB-120, are expected to start this year, pending approval from the U.S. Food and Drug Administration (FDA).

“I’m proud of how well our team has executed and advanced our platform in such a short time since the company’s founding,” Michael Torres, co-founder and CEO of CrossBridge, said in a news release. “By becoming a part of Lilly, a leader in patient-focused therapeutic development, we are well-positioned to further accelerate the clinical potential of this approach.”

Under the Lilly deal, CrossBridge shareholders were expected to receive an upfront payment along with a follow-up payment based on the achievement of certain milestones.

In 2024, CrossBridge closed a $10 million seed round. Among the investors in CrossBridge are the Texas Medical Center Venture Fund, CE-Ventures, Alexandria Venture Investments, Portal Innovations, Linden Lake Labs, and the Cancer Prevention and Research Institute of Texas (CPRIT). It was formed in TMC Innovation’s Accelerator for Cancer Therapeutics program."Built within the TMC ecosystem, CrossBridge Bio grew with the support, funding, and resources that helped shape its trajectory. TMC led the company's early financing and watched it evolve from its earliest days to its acquisition by Eli Lilly," William McKeon, president and CEO of the Texas Medical Center, shared in a LinkedIn post. "[This is a] strong reminder that breakthrough science and the right early backing can change what’s possible."
View All Listings